Keynote & Plenary Speakers

The conference will bring together national and international experts in drug prevention, treatment and care and will feature a broad range of topics and formats.

Keynote sessions will cover the following topics:

  • Genetics and neurobiology
  • Prevention and treatment innovations
  • Prevention and treatment systems
  • Social determinants
  • Law enforcement, criminal justice and health cooperation
  • Overdose prevention
  • Special populations

Please find information on our keynote and plenary speakers below:


Aala El-Khani

Honorary Research Associate University of Manchester, Consultant, UNODC

Prevention and child protection amongst refugees; displaced populations


Annette Dale-Perera

Director, ADP Consultancy UK

Consultant, UNODC

Quality assurance mechanisms


Charlotte Colman

Professor, Drug Policy and Criminal Policy, Ghent University

Treatment as an alternative; criminal justice


Federica Vigna-Taglianti

Associate Professor of Public Health, Department of Clinical and Biological Sciences University of Turin

Unplugged in Nigeria


Gregor Burkhart

Principal Scientific Analyst Public Health Unit, EMCDDA

Registry of evidence-based programmes


Jallal Toufiq

Professor of Psychiatry, Rabat Faculty of Medicine

Treatment Innovations
European Neighbours and Beyond


José Szapocznik

Director, Brief Strategic Family Therapy Institute, University of Miami Miller School of Medicine

Family Therapy


Melody Heaps

Treatment Alternatives for Safe Communities (TASC)

Treatment as an alternative


Paul Dietze

Programme Director, Behaviours and Health Risks, Burnet Institute

Opioid overdose prevention

Sanela TalicSanela Talić

Head of Prevention Programmes - Institute of Research and Development (UTRIP)

Prevention Practice – Quo Vadis


Teresa Salvador-Llivina

Director, COPOLAD

Quality assurance mechanisms


  Thomas Clausen

  Professor, Norwegian Centre for Addiction Research

  Overdose prevention


Zili Sloboda, Sc.D.

President, Applied Prevention Science International (APSI)

Prevention Innovations: Development of the Workforce

Yifrah Kaminer

Yifrah Kaminer MD., MBA

Professor of Psychiatry and Paediatrics, Alcohol Research Centre & Injury Prevention Centre, University of Connecticut School of Medicine

Neurobiology of Addiction


Otto Kernberg

Otto Kernberg, MD

Professor of Psychiatry, Weill Cornell Medical College

Neurobiology of Addiction



Laurie Krom

Laurie Krom

Collaborative to Advance Health Services, University of Missouri-Kansas City

Transforming the Workforce through Intensive Technical Assistance

Dr Roger Peters

Dr Roger Peters

Professor, University of South Florida, Department of Mental Health Law and Policy

Justice Populations with Substance Use and Co-Occurring Mental Disorders

Dr J Randy Koch

Dr J Randy Koch

Department of Psychology, Virginia Commonwealth University

Using Patient Surveys as Key Part of your Quality Assurance Plan

Peer Van der Kreeft

Peer Van Der Kreeft

HoGent-University College Ghent, Faculty for Education, Health and Social Work

EUPC, the European Universal Prevention Curriculum adaptation and training


Nick Danziger

Nick Danziger

Photographer, Film Maker and Travel Writer

Each person counts: The world drug problem in photographs

Phaedon Kaloterakis

Phaedon Kaloterakis

Assistant Director of KETHEA

Why Therapeutic Communities are Relevant Today